Institutional investors hold a majority ownership of CTLT through the 98.93% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended March 2019, these large investors purchased a net $5.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ROYAL LONDON ASSET MANAGEMENT LT... Bought 58.1 Thousand shares of Catalent Inc
LYXOR INTERNATIONAL ASSET MANAGE... Bought 34.5 Thousand shares of Catalent Inc
WEATHERBIE CAPITAL LLC Bought 22.7 Thousand shares of Catalent Inc